Effect of tamoxifen on endometrial proliferation

Journal of Clinical Oncology

Volumn 14, Issue 2, 1996, Pages 434-440

  Decensi, A ^a   Fontana, V ^a   Bruno, S ^a   Gustavino, C ^a   Gatteschi, B ^a   Costa, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; TAMOXIFEN CITRATE;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RISK; CLINICAL ARTICLE; DRUG EFFECT; ENDOMETRIUM; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0030033914     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.2.434     Document Type: Article

References (38)

1. Fugh-Berman A, Epstein S: Tamoxifen: Disease prevention or disease substitution? Lancet 340:1143-1145, 1992
2. Powles TJ: The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet 340:1145-1147, 1992
3. Marshall E: Tamoxifen: Hanging in the balance. Science 264:1524-1527, 1994
4. Friedman MA, Trimble EL, Abrams JS: Tamoxifen: Trials, tribulations, and trade-offs. J Natl Cancer Inst 86:78-79, 1994
5. Fornander T, Rutqvist LE, Cedermark B, et al: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1:117-119, 1989
6. Andersson M, Storm HH, Mouridsen HT: Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer. Acta Oncol 31:259-263, 1992
7. Fisher B, Costantino JP, Redmond CK, et al: Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527-537, 1994
8. Seachrist L: Restating the risks of tamoxifen. Science 263:910-911, 1994
9. Merkel DE, McGuire WL: Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer 65:1194-1205, 1990
10. Hendrickson MR, Kempson RL: Endometrial hyperplasia, metaplasia and carcinoma, In Fox H (ed): Obstetrical and Ginaecological Pathology. Edinburgh, Scotland, Churchill Livingstone, 1987, pp 354-362
11. Lee J: Cumulative logit modelling for ordinal response variables: Applications to biomedical research. Comput Appl Biosci 8:555-562, 1992
12. Agresti A: Categorical Data Analysis. New York, Wiley, 1990
13. Doll R: An epidemiological perspective of the biology of cancer. Cancer Res 38:3573-3583, 1978
14. Van Leeuwen FE, Rookus MA: The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer. Eur J Cancer Clin Oncol 25:1961-1972, 1989
15. Han X, Liehr JG: Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res 52:1360-1363, 1992
16. Malfetano JH: Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients. Gynecol Oncol 39:82-84, 1990
17. Segna RA, Dotting PR, Deligdisch L, et al: Tamoxifen and endometrial cancer. Mt Sinai J Med 59:416-418, 1992
18. Magriples U, Naftolin F, Schwartz PE, et al: High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11:485-490, 1993
19. Fornander T, Hellström A-C, Moberger B: Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. J Natl Cancer Inst 85:1850-1855, 1993
20. Rutquist LE, Johansson H, Signomklao T, et al: Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 87:645-651, 1995
21. Nephew KP, Polek TC, Akcali KC, et al: The antiestrogen tamoxifen induces c-fos and jun-B, but not c-jun or jun-D, protooncogenes in the rat uterus. Endocrinology 133:419-422, 1993
22. Branham WS, Zehr DR, Sheehan DM: Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc Soc Exp Biol Med 203:297-303, 1993
23. Bayer SR, DeCherney AH: Clinical manifestations and treatment of dysfunctional uterine bleeding. JAMA 269:1823-1828, 1993
24. Parazzini F, La Vecchia C, Bocciolone L, et al: The epidemiology of endometrial cancer. Gynecol Oncol 41:1-16, 1991
25. Adami H-O, Krusemo UB, Bergkvist L, et al: On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study. Br J Cancer 55:77-80, 1987
26. Ewertz M, Storm HH: Multiple primary cancers of the breast, endometrium and ovary. Eur J Cancer Clin Oncol 25:1927-1932, 1989
27. Nayfield SG, Karp JE, Ford LG, et al: Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83:1450-1459, 1991
28. Van Leeuwen FE, Benraadt J, Coebergh JWW, et al: Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343:448-452, 1994
29. Casta A, Jordan VC: Meeting report: Long-term antihormonal therapy for breast cancer. Eur J Cancer 27:1479-1481, 1991
30. Kedar RP, Bourne TH, Powles TJ, et al: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318-1321, 1994
31. Lindahl B, Alm P: Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment. Anticancer Res 11:391-396, 1991
32. Thornton JG, Quirke P, Wells W: Flow cytometry of normal, hyperplastic, and malignant human endometrium. A study of ploidy and proliferative indices including comparison with in vitro S-phase labeling. Am J Obstet Gynecol 161:487-492, 1989
33. Feichter GE, Höffken H, Heep J, et al: DNA-flow-cytometnc measurements on the normal, atrophie, hyperplastic and neoplastic human endometrium. Virchows Arch A Pathol Anat Histopathol 398:53-65, 1982
34. Cooke PS, Uchima F-DA, Fujii DK, et al: Restoration of normal morphology and estrogen responsiveness in cultured vaginal and uterine epithelia transplanted with stroma. Proc Natl Acad Sci USA 83:2109-2113, 1986
35. Gong Y, Ballejo G, Murphy LC, et al: Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Cancer Res 52:1704-1709, 1992
36. Hammond MG, Oh S-T, Anners J, et al: The effect of growth factors on the proliferation of human endometrial stromal cells in culture. Am J Obstet Gynecol 168:1131-1138, 1993
37. Huynh HT, Pollak M: Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res 53:5585-5588, 1993
38. Sporn MB: Chemoprevention of cancer. Lancet 342:1211-1213, 1993